A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
Clinical trial NCT02965573 · COMPLETED
Trial details
- NCT number
- NCT02965573
- Sponsor
- argenx
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-30
- Primary completion
- 2017-10-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.